Amneal Pharmaceuticals, Inc. (AMRX)
13.39
-0.19
(-1.40%)
USD |
NASDAQ |
Jan 23, 16:00
13.36
-0.03
(-0.22%)
After-Hours: 20:00
Amneal Pharmaceuticals EPS Diluted (Quarterly): 0.0073 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Corcept Therapeutics, Inc. | 0.1621 |
| Merck & Co., Inc. | 2.316 |
| Nektar Therapeutics | -1.875 |
| Innoviva, Inc. | 1.082 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.13M |
| Revenue (Quarterly) | 784.51M |
| Total Expenses (Quarterly) | 782.14M |
| Enterprise Value | 6.726B |
| Gross Profit Margin (Quarterly) | 34.92% |
| Profit Margin (Quarterly) | 2.31% |
| Earnings Yield | 0.11% |
| Operating Earnings Yield | 8.50% |
| Normalized Earnings Yield | 0.8028 |